Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Jun;215(6):618–626. doi: 10.1097/00000658-199206000-00008

Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.

C B Davies 1, J W Alexander 1, B R Cofer 1, M R First 1, T J Schroeder 1
PMCID: PMC1242515  PMID: 1632683

Abstract

During the 7-year period from March 1984 to June 1991, 86 haploidentical living related kidney recipients were entered into one of three donor-specific transfusion (DST) and cyclosporine treatment protocols: (1) Multiple pretransplant DSTs with cyclosporine begun after transplant, n = 34; (2) Multiple pretransplant DSTs with cyclosporine begun pretransplant, n = 31; and (3) a single DST 24 to 48 hours before transplant with intravenous cyclosporine initiated after the transfusion, n = 21. Triple immunosuppression (prednisone, azathioprine, and cyclosporine) was continued in all groups after transplant. The 1-year patient (97%, 97%, and 93%, p = not significant) and graft (91%, 90%, and 87%, p = not significant) survival were similar for the three groups. No differences were seen in the incidence of rejection at 1 year (61%, 45%, and 60%, p = not significant) or in the incidence of infectious complications (26%, 42%, and 47%, p = not significant). It is concluded that a single DST given 24 to 48 hours before operation followed by pretransplant cyclosporine is as effective as classic DST conditioning of recipients using either pretransplant or post-transplant cyclosporine. The single DST protocol has the advantage of not eliminating any donors because of sensitization and was less costly and easier to administer.

Full text

PDF
618

Images in this article

622FIG. 3.
on p.622
623FIG. 4.
on p.623

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. W., Babcock G. F., First M. R., Davies C. B., Madden R. L., Munda R., Penn I., Fidler J. P., Cofer B. R., Stephens G. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial. Transplantation. 1992 Feb;53(2):423–427. doi: 10.1097/00007890-199202010-00030. [DOI] [PubMed] [Google Scholar]
  2. Anderson C. B., Sicard G. A., Etheredge E. E. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products. Surgery. 1982 Aug;92(2):315–321. [PubMed] [Google Scholar]
  3. Barber W. H., Hudson S. L., Deierhoi M. H., Laskow D. A., Gaston R. S., Julian B. A., Curtis J. J., Diethelm A. G. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients. Clin Transpl. 1990:289–300. [PubMed] [Google Scholar]
  4. Bean M. A., Mickelson E., Yanagida J., Ishioka S., Brannen G. E., Hansen J. A. Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype. Transplantation. 1990 Feb;49(2):382–386. doi: 10.1097/00007890-199002000-00031. [DOI] [PubMed] [Google Scholar]
  5. Brunson M. E., Tchervenkov J. I., Alexander J. W., Cofer B. R. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine. Transplant Proc. 1991 Feb;23(1 Pt 1):307–308. [PubMed] [Google Scholar]
  6. Brunson M. E., Tchervenkov J. I., Alexander J. W. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine. Transplantation. 1991 Sep;52(3):545–549. doi: 10.1097/00007890-199109000-00032. [DOI] [PubMed] [Google Scholar]
  7. Burlingham W. J., Sparks E. M., Sondel P. M., Glass N. R., Belzer F. O., Sollinger H. W. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response. Transplantation. 1985 Jan;39(1):12–17. [PubMed] [Google Scholar]
  8. Cheigh J. S., Suthanthiran M., Fotino M., Riggio R. R., Schechter N., Stubenbord W. T., Stenzel K. H., Rubin A. L. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Transplantation. 1991 Feb;51(2):378–381. doi: 10.1097/00007890-199102000-00021. [DOI] [PubMed] [Google Scholar]
  9. Cofer B. R., Tchervenkov J. I., Alexander J. W., Barnwell S. C. Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period. Transplant Proc. 1991 Feb;23(1 Pt 1):157–158. [PubMed] [Google Scholar]
  10. Garcia V. D., Kraemer E. S., Prompt C. A., Santos A., Caovila J., Duarte A., Filho A. N., Goldani J. C. Donor specific blood transfusions do not improve graft survival in living related donor transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2271–2273. [PubMed] [Google Scholar]
  11. Glass N. R., Miller D. T., Sollinger H. W., Belzer F. O. A four-year experience with donor blood transfusion protocols for living-donor renal transplantation. Transplantation. 1985 Jun;39(6):615–619. doi: 10.1097/00007890-198506000-00008. [DOI] [PubMed] [Google Scholar]
  12. Grailer A. P., Sollinger H. W., Kawamura T., Burlingham W. J. Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patients pretreated with donor-specific transfusions. Transplantation. 1991 Feb;51(2):320–324. doi: 10.1097/00007890-199102000-00009. [DOI] [PubMed] [Google Scholar]
  13. Groth C. G. There is no need to give blood transfusions as pretreatment for renal transplantation in the cyclosporine era. Transplant Proc. 1987 Feb;19(1 Pt 1):153–154. [PubMed] [Google Scholar]
  14. Hadley G. A., Kenyon N., Anderson C. B., Mohanakumar T. Downregulation of antidonor cytotoxic lymphocyte responses in recipients of donor-specific transfusions. Transplantation. 1990 Dec;50(6):1064–1066. doi: 10.1097/00007890-199012000-00038. [DOI] [PubMed] [Google Scholar]
  15. Leivestad T., Albrechtsen D., Flatmark A., Thorsby E. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens. Transplantation. 1986 Jul;42(1):35–38. [PubMed] [Google Scholar]
  16. Leivestad T., Thorsby E. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness. Transplantation. 1984 Feb;37(2):175–181. doi: 10.1097/00007890-198402000-00012. [DOI] [PubMed] [Google Scholar]
  17. Oluwole S. F., Fawwaz R. A., Reemtsma K., Hardy M. A. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine. Transplantation. 1988 Jun;45(6):1131–1135. doi: 10.1097/00007890-198806000-00027. [DOI] [PubMed] [Google Scholar]
  18. Opelz G., Sengar D. P., Mickey M. R., Terasaki P. I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973 Mar;5(1):253–259. [PubMed] [Google Scholar]
  19. Reed A., Pirsch J., Armbrust M. J., Burlingham W. J., Knechtle S. J., D'Alessandro A. M., Sollinger H. W., Lorentzen D., Kalayoglu M., Belzer F. O. Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. Transplantation. 1991 Feb;51(2):382–384. doi: 10.1097/00007890-199102000-00022. [DOI] [PubMed] [Google Scholar]
  20. Salvatierra O., Jr, Melzer J., Vincenti F., Amend W. J., Jr, Tomlanovich S., Potter D., Husing R., Garovoy M., Feduska N. J. Donor-specific blood transfusions versus cyclosporine--the DST story. Transplant Proc. 1987 Feb;19(1 Pt 1):160–166. [PubMed] [Google Scholar]
  21. Salvatierra O., Jr, Vincenti F., Amend W., Potter D., Iwaki Y., Opelz G., Terasaki P., Duca R., Cochrum K., Hanes D. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg. 1980;192(4):543–552. doi: 10.1097/00000658-198010000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Salvatierra O., McVicar J., Melzer J., Amend W., Vincenti F., Tomlanovich S., Husing R., Rabkin J., Garovoy M. Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol. Transplant Proc. 1991 Feb;23(1 Pt 2):1024–1026. [PubMed] [Google Scholar]
  23. Schroeder T. J., Brunson M. E., Pesce A. J., Hindenlang L. L., Mauser P. A., Ruckrigl D. I., Weibel M. L., Wadih G., First M. R. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients. Transplantation. 1989 Feb;47(2):262–266. doi: 10.1097/00007890-198902000-00013. [DOI] [PubMed] [Google Scholar]
  24. Sells R. A., Scott M. H., Prieto M., Bone J. M., Evans G. M., Millar R., Hills A. N. Early rejection following donor-specific transfusion prior to HLA-mismatched living related renal transplantation. Transplant Proc. 1989 Feb;21(1 Pt 1):1173–1174. [PubMed] [Google Scholar]
  25. Tchervenkov J. I., Epstein M. D., Alexander J. W., Schroeder T. J. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival. Transplantation. 1989 Jan;47(1):177–181. doi: 10.1097/00007890-198901000-00037. [DOI] [PubMed] [Google Scholar]
  26. Tsuda T., Kahan B. D. A potential synergistic effect of donor antigenic extracts and cyclosporine on the prolongation of rat renal allografts. Transplantation. 1983 May;35(5):483–489. doi: 10.1097/00007890-198305000-00018. [DOI] [PubMed] [Google Scholar]
  27. Whelchel J. D., Curtis J. J., Barger B. O., Luke R. G., Diethelm A. G. The effect of pretransplant stored donor-specific blood transfusion on renal allograft survival in one-haplotype living-related transplant recipients. Transplantation. 1984 Dec;38(6):654–656. doi: 10.1097/00007890-198412000-00021. [DOI] [PubMed] [Google Scholar]
  28. Yasumura T., Kahan B. D. Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. Transplantation. 1983 Dec;36(6):603–609. doi: 10.1097/00007890-198336060-00002. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES